An article called “Young adults with ALL have better survival with pediatric regimens” (published December 8, 2014) incorrectly described the treatment received by study patients. The patients were treated with the same, intensive pediatric chemotherapy combination regimen.
FROM ASH 2017 Chimeric antigen receptor (CAR) T-cell therapies are driving ever faster forward, ...
EXPERT ANALYSIS FROM RWCS 2018 MAUI, HAWAII (FRONTLINE MEDICAL NEWS) – Rheumatologists can save ...
AT SID 2017 PORTLAND, ORE. (FRONTLINE MEDICAL NEWS) – Comorbidities were common in patients ...
